Fig. 5From: Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genesValidation of the metabolism-based prognostic risk signature in the GSE31210 cohort. a The risk score distribution of LUAD patients; b Survival status and duration of patients; c Heatmap of the metabolism-related genes expression; d Survival curves for the low risk and high risk groups; e Time-independent ROC analysis of risk scores for prediction the overall survival in the GSE31210 datasetBack to article page